Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Sensors (Basel) ; 21(6)2021 Mar 11.
Article in English | MEDLINE | ID: mdl-33799891

ABSTRACT

Industrial Cyber-Physical System (CPS) is an emerging approach towards value creation in modern industrial production. The development and implementation of industrial CPS in real-life production are rewarding yet challenging. This paper aims to present a concept to develop, commercialize, operate, and maintain industrial CPS which can motivate the advance of the research and the industrial practice of industrial CPS in the future. We start with defining our understanding of an industrial CPS, specifying the components and key technological aspects of the industrial CPS, as well as explaining the alignment with existing work such as Industrie 4.0 concepts, followed by several use cases of industrial CPS in practice. The roles of each component and key technological aspect are described and the differences between traditional industrial systems and industrial CPS are elaborated. The multidisciplinary nature of industrial CPS leads to challenges when developing such systems, and we present a detailed description of several major sub-challenges that are key to the long-term sustainability of industrial CPS design. Since the research of industrial CPS is still emerging, we also discuss existing approaches and novel solutions to overcome these sub-challenges. These insights will help researchers and industrial practitioners to develop and commercialize industrial CPS.

2.
Chembiochem ; 10(6): 994-8, 2009 Apr 17.
Article in English | MEDLINE | ID: mdl-19267375

ABSTRACT

New and improved: The incorporation of a 6-chlorotryptophan (6-Cl-Trp) into a beta-peptide (M)-3(14) helix leads to a high-affinity hDM2 inhibitor, as demonstrated by fluorescence fluctuation analysis at single molecule resolution. When conjugated to penetratin, the newly derived hDM2 binder specifically inhibits tumour cell growth in vitro.


Subject(s)
Peptides/metabolism , Peptides/pharmacology , RNA-Binding Proteins/metabolism , Tumor Suppressor Protein p53/metabolism , Amino Acid Sequence , Animals , Biomimetic Materials/chemical synthesis , Biomimetic Materials/chemistry , Biomimetic Materials/metabolism , Biomimetic Materials/pharmacology , Cell Line, Tumor , Drug Design , Humans , Ligands , Mice , Models, Molecular , Peptides/chemical synthesis , Peptides/chemistry , Protein Binding/drug effects , Protein Structure, Secondary , Tumor Suppressor Protein p53/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...